Go to Home
Go to About the Exchange
Go to Browse Innovations Exchange by Subject
QualityTools
Go to Learn & Network
Go to Resources
Go to Submit Your Innovation
Go to AHRQ Funding Opportunities
Go to FAQs
Go to Contact Us
 
< Back
QualityTool Icon QualityTool:

White Blood Cell Growth Factors: 2006 Update, American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Slide Set


square iconDescription

This slideshow presents a summary of the American Society of Clinical Oncology (ASCO) guidelines for white blood cell growth factors.

This slideshow addresses the following topics:

  • Guideline methodology
  • 2006 recommendation categories (12) for the use of colony-stimulating factors (CSF)
  • 2006 updated recommendation
  • Incidence of hematologic and infectious toxicities with selected chemotherapy regimens
  • Primary prophylactic CSF administration (first and subsequent-cycle use)
  • Secondary prophylactic CSF administration
  • Therapeutic use of CSF
  • CSF to increase chemotherapy dose-intensity and dose-density
  • CSF as adjuncts to progenitor-cell transplantation
  • CSF in patients with acute leukemia and myelodysplastic syndromes
  • CSF in patients receiving radiotherapy with/without concurrent chemotherapy
  • CSF in older patients
  • CSF in the pediatric population
  • CSF initiation, duration, dosing, and administration
  • Special comment: comparative clinical activity of granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF)
  • Special comment: growth factors as treatment for radiation injury
  • Impact of CSF on quality of life and health care costs
  • Summary

Links to the Tool:
This tool is available at: http://www.asco.org/ASCO/Downloads/Cancer%20Policy%20and%20Clinical%20Affai rs/Clinical%20Affairs%20(derivative%20products)/CSF%20slides-v1.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software.)

Developer

American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline:
http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=9419

History

  • Release Date: 05/2006
  • Original Summary: 06/2006
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Disease/Clinical Category: spacer Chemotherapy; Hematopoietic growth factor; Neutropenia, febrile
Patient Population: spacer Vulnerable Populations > Children; Frail elderly
Stage of Care: spacer Acute care
Patient Care Process: spacer Active Care Processes: Diagnosis and Treatment > Assessment; Medication: ordering, transcription, administration, dispensing; Care Management Processes > Coordination of care
IOM Domains of Quality: spacer Effectiveness
QualityTool Format: spacer Slide Presentation/Video/DVD
QualityTool Topic: spacer Disease/Condition-Related; Guideline-Related
Developer: spacer American Society of Clinical Oncology
Funding Sources: spacer American Society of Clinical Oncology

 

Last updated: April 11, 2008.

 

 spacer
 
 
AHRQ Advancing Excellence in Health Care